Thalomid patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7230012 CELGENE Pharmaceutical compositions and dosage forms of thalidomide
Dec, 2023

(2 months from now)

Thalomid is owned by Celgene.

Thalomid contains Thalidomide.

Thalomid has a total of 1 drug patent out of which 0 drug patents have expired.

Thalomid was authorised for market use on 16 July, 1998.

Thalomid is available in capsule;oral dosage forms.

The generics of Thalomid are possible to be released after 09 December, 2023.

Drugs and Companies using THALIDOMIDE ingredient

Market Authorisation Date: 16 July, 1998

Treatment: NA


How can I launch a generic of THALOMID before it's drug patent expiration?
More Information on Dosage

THALOMID family patents

Family Patents

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic